reMYND
Roche signs Alzheimer’s deal with reMYND
September 7, 2010Research and Development Alzheimer's, Parkinson's, Roche, reMYND
Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
